This map shows the geographic impact of E Krykowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Krykowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Krykowski more than expected).
This network shows the impact of papers produced by E Krykowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Krykowski. The network helps show where E Krykowski may publish in the future.
Co-authorship network of co-authors of E Krykowski
This figure shows the co-authorship network connecting the top 25 collaborators of E Krykowski.
A scholar is included among the top collaborators of E Krykowski based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with E Krykowski. E Krykowski is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Marczak, Agnieszka, et al.. (2003). The interaction of daunorubicin and mitoxantrone with the red blood cells of acute myeloid leukemia patients.. PubMed. 8(4). 885–90.9 indexed citations
Kiliańska, Zofia M., Anetta Ptasinska, Jerzy Z. Błoński, et al.. (1998). Immunospecific protein with mol.WT of 38-39 kDa from lymphocytic leukemic cells. Cellular & Molecular Biology Letters. 3(1).
7.
Smolewski, Piotr, et al.. (1998). Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease.. PubMed. 45(3). 140–7.24 indexed citations
Krykowski, E, Krzysztof Warzocha, & Tadeusz Robak. (1995). 2-Chlorodeoxyadenosine (2-CdA) in the treatment of patients with relapsed chronic lymphocytic leukemia.. PubMed. 43(5-6). 317–21.3 indexed citations
14.
Robak, Tadeusz, E Krykowski, & Krzysztof Warzocha. (1994). Treatment of chemotherapy-induced or idiopathic bone marrow aplasia with granulocyte colony-stimulating factor (G-CSF).. PubMed. 42(5-6). 433–8.
15.
Błasińska-Morawiec, Maria, et al.. (1991). [Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and prednisone)].. PubMed. 86(4). 274–80.1 indexed citations
Woźniak, L, et al.. (1981). Observations on angioimmunoblastic lymphadenopathy.. PubMed. 22(1). 81–95.2 indexed citations
18.
Wozniak, Laura J., et al.. (1978). [Case of chronic exacerbated generalized toxoplasmosis coexistent with autoimmunohemolytic anemia].. PubMed. 24(4). 441–9.3 indexed citations
19.
Krykowski, E, et al.. (1975). [Preleukemic conditions presenting as failure of bone marrow tissue].. PubMed. 30(1). 23–5.
20.
Musiał, W, et al.. (1966). [Studies on anemia in pregnancy].. PubMed. 21(9). Suppl:88–90.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.